The clinical utility of reticular basement membrane thickness measurements in asthmatic children

Area of Science:

• Pediatric Pulmonology
• Respiratory Pathology
• Diagnostic Biomarkers

Background:

• Reticular basement membrane (RBM) thickness is a recognized pathological feature in asthma.
• Measuring RBM thickness in endobronchial biopsies is a potential diagnostic approach.
• Assessing the feasibility and clinical utility of RBM thickness in pediatric asthma diagnosis is crucial.

Purpose of the Study:

• To evaluate the feasibility of obtaining endobronchial biopsies for RBM thickness measurement in a clinical setting.
• To investigate the diagnostic value of RBM thickness for asthma in children.
• To correlate RBM thickness with asthma severity in pediatric patients.

Main Methods:

• A cohort of children undergoing bronchoscopy with endobronchial mucosal biopsies was analyzed.
• Patients were stratified into three groups: no asthma, mild-moderate asthma, and problematic severe asthma.
• Reticular basement membrane thickness was measured in retrieved biopsies.

Main Results:

• Adequate biopsies for RBM measurement were obtained in 71% of pediatric patients (n=152).
• Mean RBM thickness showed significant differences among the no asthma, mild-moderate asthma, and severe asthma groups (p=0.04).
• The observed differences in RBM thickness were no longer significant when exhaled nitric oxide was included in the analysis.

Conclusions:

• Endobronchial biopsies for RBM thickness measurement are feasible in routine pediatric care.
• While RBM thickness differs between asthmatic and non-asthmatic children, it lacks added clinical diagnostic value for childhood asthma.
• Exhaled nitric oxide may be a more significant factor in asthma diagnosis than RBM thickness alone.